Migraine Trust International Symposium

Dr Frank Porreca On Future Areas of Focus in Migraine Research

October 08, 2020

The future of migraine research will include further investigations into understanding the pathophysiology of migraine outside of CGRP, said Frank Porreca, PhD, professor of pharmacology and anesthesiology at the University of Arizona and a member of the Department of Collaborative Research at Mayo Clinic in Arizona.

Dr Peter McAllister Offers the HCP Perspective on the Benefits of Migraine Prevention

October 07, 2020

Migraine prevention helps drive down functional disability among migraineurs, said Peter McAllister, MD, a neurologist, board certified headache specialist, and medical director of the New England Institute for Neurology and Headache.

What the Migraine Field Knows in the 2 Years Since Launch of CGRPs

October 07, 2020

The entry of a new class of migraine therapies has created a new wave of excitement. A presentation at the Migraine Trust International Symposium reviewed what clinicians now know about calcitonin gene-related peptide (CGRP) blockers.

Dr Stephen Silberstein Compares the Effects of Erenumab on Chronic, Episodic Migraine

October 07, 2020

Because patients with chronic migraine experience more monthly migraine days (MMD) than those with episodic migraine, chronic migraineurs will experience a greater reduction of MMD with erenumab, said Stephen Silberstein, MD, professor of neurology at Thomas Jefferson University and director of the Headache Center at Jefferson Health.

Unearthing the Year’s Clinical Highlights in Migraine

October 06, 2020

At a session Tuesday at the Migraine Trust International Symposium, one presentation delved into findings published this year in medication overuse headaches, prevention, and pathophysiology of migraine as well as cluster headaches.

Did the COVID-19 Pandemic Alter Migraine Attack Frequency, Triggers?

October 06, 2020

Compared with 2018 and 2019, data from 2020 show reports of headache frequency increased, despite decreases in reports of the 4 most common migraine triggers, said Faraidoon Haghdoost, MD, a general practitioner and PhD student at The George Institute for Global Health in Sydney, Australia.